Pharma Mar SA
Iwein D'herdt has extensive experience in the pharmaceutical industry, with a focus on key account management and sales. Iwein has held various positions at companies such as PharmaMar, Chugai Pharma Europe Ltd, Docpharma, Novartis, and AstraZeneca. Iwein has played a crucial role in managing relationships with major buyers in the industry. Iwein's education was completed at Ghent University from 1975 to 1980.
This person is not in any offices
Pharma Mar SA
Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical diseases areas. It manufactures and sells Yondelis, a synthetically modified antitumor agent, which is derived from sea squirts and is implemented in the treatment of soft tissue sarcomas and relapsed ovarian cancer. Furthermore, the Company's products pipeline comprises drug candidates and agents for cancer treatment, such as Aplidin, PM01183 and PM060184. The Company operates through subsidiaries in Italy, Germany, France, and the United States, among others.